| Q37975223 | A crosstalk between bone and gonads. |
| Q34635732 | Androgen effects on bone and muscle |
| Q79811504 | Androgens and bone |
| Q34577452 | Bone mineral density in women with polycystic ovary syndrome |
| Q37818155 | Circulating androgens in women: exercise-induced changes |
| Q92325270 | Evolutionary origins of polycystic ovary syndrome: An environmental mismatch disorder |
| Q83145582 | GH-binding protein is related to bone mineral density in non-obese androgenized women |
| Q44442555 | Hyperandrogenicity is an alternative mechanism underlying oligomenorrhea or amenorrhea in female athletes and may improve physical performance |
| Q34982190 | Hyperandrogenism in female athletes with functional hypothalamic amenorrhea: a distinct phenotype. |
| Q37222857 | Myo-Inositol in the Treatment of Teenagers Affected by PCOS. |
| Q34212179 | Polycystic ovary syndrome, androgen excess, and the impact on bone. |
| Q35023586 | Relationships among body mass, its components, and bone |
| Q34777753 | The effects of metformin with lifestyle therapy in polycystic ovary syndrome: a randomized double-blind study. |
| Q34995316 | The pathogenesis of osteoporosis in older women and men: a review |
| Q35108989 | The role of estrogens in men and androgens in women. |